1. 302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumors. (September 2015) Authors: Italiano, A.; Keilhack, H.; Toulmonde, M.; Coindre, J.M.; Michot, J.M.; Massard, C.; Ottesen, L.; Reyderman, L.; Blakemore, S.J.; Kraljevic, S.; Thomson, B.; McDonald, A.; Ho, P.T.; Ribrag, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Medium-Throughput Single Cell CRISPR-Cas9 Assay to Assess Gene Essentiality. Issue 1 (December 2015) Authors: Grassian, A.; Scales, T.; Knutson, S.; Kuntz, K.; McCarthy, N.; Lowe, C.; Moore, J.; Copeland, R.; Keilhack, H.; Smith, J.; Wickenden, J.; Ribich, S. Journal: Biological procedures online Issue: Volume 17:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗